If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.75
Bid: 8.50
Ask: 9.00
Change: 0.81 (10.20%)
Spread: 0.50 (5.882%)
Open: 8.25
High: 8.75
Low: 8.25
Prev. Close: 7.94
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Takeover Code Form 8.3 - Belluscura plc

16 Oct 2023 07:00

RNS Number : 1479Q
Tekcapital plc
16 October 2023

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Full name of discloser:

TEKCAPITAL PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Belluscura plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

16 October 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

1p Ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

15,138,767

11.01%

0

0

(2) Cash-settled derivatives:

0

0

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

0

0

TOTAL:

15,138,767

11.01%

0

0

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

16/10/2023

Contact name:

Max Inglis

Telephone number*:

+44 (0)7779 306653

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETFLFEVIILELIV
Date   Source Headline
2nd Oct 20187:01 amRNSGuident Ltd Appoints Chairman
2nd Oct 20187:00 amRNSPlacing to raise approximately $1.15million
17th Sep 20187:00 amRNSBelluscura PLC Expands its Patent Portfolio
7th Sep 20187:00 amRNSAppointment of Joint Broker
21st Aug 20182:04 pmRNSHolding(s) in Company
14th Aug 20187:00 amRNSHalf-year Report
6th Aug 20187:00 amRNSMarketing & Technology Transfer Hub
3rd Aug 20187:00 amRNSLucyd Pte Ltd. Launches eShop
1st Aug 20187:00 amRNSSalarius Ltd Appoints CEO
4th Jul 20187:00 amRNSLucyd Pte Ltd. Update
29th Jun 20187:00 amRNSChange of Adviser
30th May 201812:53 pmRNSResult of Annual General Meeting
29th May 20187:00 amRNSHolding(s) in Company
22nd May 20187:00 amRNSLucyd Appoints Global Marketing Manager
22nd May 20187:00 amRNSSalarius Ltd Appoints Directors
17th May 20187:00 amRNSPrivate Placement for Belluscura plc
15th May 20181:17 pmRNSHolding(s) in Company
10th May 20187:00 amRNSHolding(s) in Company
8th May 20187:00 amRNSUniversity Technology Commercialization Programme
4th May 20181:45 pmRNSFinal Results
19th Apr 20187:00 amRNSUK Investor Show
1st Mar 20187:00 amRNSUpdate on Lucyd Blockchain Token Generation Event
14th Feb 20187:00 amRNSPrivate Placement for Belluscura to raise US$1.33m
24th Jan 20187:00 amRNSHolding(s) in Company
22nd Jan 20187:00 amRNSUpdate on Lucyd Blockchain Token Generation Event
18th Dec 20174:14 pmRNSHolding(s) in Company
1st Dec 201710:14 amRNSUpdate re. Belluscura IPO
16th Nov 20178:00 amRNSUpdate re. Belluscura IPO
30th Oct 20177:00 amRNSAcquisition of a Patented AI Valet System
28th Sep 20177:00 amRNSPortfolio Company to Raise Funds via a Token Sale
22nd Sep 20177:00 amRNSInvestor Briefing
31st Jul 20177:00 amRNSHalf-year Report
31st May 201711:18 amRNSResult of AGM
31st May 20177:00 amRNSAcquisition of New Gesture Recognition Technology
9th May 20175:13 pmRNSFinal Results
8th May 20179:11 amRNSNotice of AGM
3rd May 20177:00 amRNSPrivate Placement for Belluscura Ltd
2nd May 20179:31 amRNSApp to Search Global University IP
25th Apr 20177:00 amRNSBelluscura acquires Nanotether Discovery Science
20th Mar 20179:11 amRNSHolding(s) in Company
16th Mar 20179:30 amRNSHolding(s) in Company
10th Mar 20179:31 amRNSExercise of Warrants
3rd Mar 20177:00 amRNSBelluscura Launches Passport Medical Device in US
2nd Mar 20177:00 amRNSBelluscura Ltd Launches Slyde in EU
1st Mar 20177:00 amRNSBelluscura Ltd Launches Wire CaddyT In USA
28th Feb 20177:00 amRNSLicense and Development Agreement
15th Feb 20177:00 amRNSAppointment of Joint Broker
2nd Feb 20179:55 amRNSHolding(s) in Company
1st Feb 20175:25 pmRNSHolding(s) in Company
31st Jan 20174:26 pmRNSTotal Voting Rights and Holding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.